A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Helixate


CSL Behring's Helixate(R) FS and Mix2Vial(TM) Now Packaged ...  -  Feb 25, 2007
Drug Newswire (press release),..."By packaging this technology together with Helixate FS and a 2.5 mL sterile water diluent that can be used for all potencies, we are providing patients,

CSL Behring's Helixate(R) FS and Mix2Vial(TM) Now Packaged ...  -  Feb 20, 2007
PR Newswire (press release),..."By packaging this technology together with Helixate FS and a 2.5 mL sterile water diluent that can be used for all potencies, we are providing patients,

CSL Behring and Bayer Extend Agreement for Supply of Helixate ...  -  Feb 2, 2007
PharmaLive.com (press release),Under the contract extension, Bayer will continue to supply Helixate (R) recombinant coagulation Factor VIII to CSL Behring through 2017.

CSL Behring and Bayer Extend Agreement for Supply of Helixate(R ...  -  Feb 1, 2007
PR Newswire (press release),..."Under this agreement we will have the ability to increase the supply of Helixate available for our customers. We highly value our long-term relationship

CSL Secures Long Term Supply of Helixate from Bayer  -  Feb 2, 2007
PharmaLive.com (press release),CSL advised that the previous agreement with Bayer on Helixate FS would have expired in 2009, with the new arrangement securing supply for a further eight

CSL extends agreement for drug Helixate  -  Feb 1, 2007
The Australian,Sanofi-Aventis facilitated an extension of the arrangements CSL had with Bayer for the supply of Helixate FS, which is used in the treatment of haemophilia,

CSL Ltd.: Interim Result - Strong Profit from Operations, Up 46 ...  -  Feb 21, 2007
PharmaLive.com (press release),..."Other operating highlights include extending the Helixate® supply contract with Bayer until 2017 and making a final settlement with Sanofi-Aventis,

Blood product deal gives CSL shares an infusion  -  Feb 2, 2007
The Age,Bayer supplies CSL with the recombinant blood-clotting product Kogenate, which CSL sells under the brand Helixate. CSL last year made $US340 million ($A440

Bayer HealthCare and CSL Behring Extend Agreement for Supply of ...  -  Feb 2, 2007
PharmaLive.com (press release),This is also a collaboration that has served the global hemophilia community through expanded distribution of our reliable Kogenate® and Helixate® line of

Bayer, CSL Behring extend supply agreement  -  Feb 2, 2007
ReutersThe agreement, effective until 2017, comes as both companies settled outstanding litigation relating to the supply of Helixate, Bayer said in a statement.

CSL Behring and Bayer Extend Agreement Related to Hemophilia  -  Feb 2, 2007
Genetic Engineering News (press release),...of a therapy for the treatment of hemophilia A. Bayer will provide Helixate® recombinant coagulation Factor VIII to CSL Behring through 2017.

The Bloodsucker of Valentine  -  Feb 21, 2007
Pitch Weekly,The plasma is used in the manufacturing of products such as Helixate, which treats a disease that inhibits blood clotting, and TachoComb, which aids in

(PRN) - NTT America Expands Global Network With NYC Connect ... [+]  -  Feb 20, 2007
Bolsamania.com,...(PRN) - CSL Behring's Helixate(R) FS and Mix2Vial(TM) Now Packaged Together to Optimize Patient Safety and Convenience ... [+]

Australia's S&P/ASX 200 Climbs to a Record, Led by BHP and CSL  -  Feb 1, 2007
BloombergCSL was boosted after the company signed a new agreement with Sanofi-Aventis for the supply of Helixate FS, which is used in the treatment of hemophilia.

Asian Stocks Advance, On Positive US Economic Data On Personal ...  -  Feb 1, 2007
Trading Markets,3% after the company announced that it has signed a new agreement with Sanofi Aventis for supply of Helixate FS, which is used for treating hemophilia.

(PRN) - Edison Schools Disputes Flawed Findings in Philadelphia ...  -  Feb 1, 2007
Bolsamania.com,...(PRN) - CSL Behring and Bayer Extend Agreement for Supply of Helixate(R) Recombinant Coagulation Factor ... [+]. (PRN) - Aberdeen Global Income Fund,


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional